Mylerann.
/ˈmʌɪləran/, U.S. /ˈmaɪləˌræn/ Pharmacology.
A proprietary name for: the drug busulfan (busulphan).
ΘΚΠ
the world > health and disease > healing > medicines or physic > medicines for specific purpose > preparations treating or preventing specific ailments > [noun] > for cancer or leukemia
amethopterin1948
Myleran1952
Laetrile1953
thioguanine1953
thioTEPA1953
mercaptopurine1954
methotrexate1955
busulfan1956
chlorambucil1956
cyclophosphamide1960
vinblastine1962
vincristine1962
levamisole1969
vinca alkaloid1970
doxorubicin1971
tamoxifen1972
Airol1974
trastuzumab1997
thiotepa-
1952 Trade Marks Jrnl. 12 Nov. 1049/1 Myleran.
1953 Lancet 31 Jan. 207/2 ‘Myleran’..showed an intense inhibitory effect on the growth of the Walker rat carcinoma 256.
1968 Internat. Pharmacol. Abstr. 5 1509 A 26-year-old woman had to be treated with busulphan (Myleran), 2–8 mg. daily during the first to sixth and 19–30th weeks of pregnancy because of chronic myeloid leukemia.
1987 Mutation Res. 176 259 The alkylating agent busulfan (Myleran) adversely affects spermatogenesis in mammals.
2001 Acta Biologica Hungarica 52 105 The results of the present study indicate the antispermatogenic activity of Busulphan or Myleran (1,4-dimethane-sulphonoxy butane) on the testicular tissue of adult male Indian house rat.
This entry has been updated (OED Third Edition, June 2003; most recently modified version published online March 2022).
<
n.1952